$546 Million is the total value of Parkman Healthcare Partners LLC's 102 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 35.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| THC | Sell | TENET HEALTHCARE CORP | $14,900,430 | -27.9% | 226,141 | -11.0% | 2.73% | -23.8% |
| IMGN | Sell | IMMUNOGEN INC | $11,393,390 | -28.2% | 717,920 | -14.6% | 2.09% | -24.1% |
| Sell | RXSIGHT INC | $10,635,322 | -25.9% | 381,331 | -23.5% | 1.95% | -21.7% | |
| SDGR | Sell | SCHRODINGER INC | $10,421,849 | -56.7% | 368,654 | -23.6% | 1.91% | -54.3% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $9,432,563 | -28.4% | 83,845 | -40.0% | 1.73% | -24.3% |
| HAE | Sell | HAEMONETICS CORP MASS | $7,969,216 | -18.7% | 88,962 | -22.7% | 1.46% | -14.0% |
| XENE | Sell | XENON PHARMACEUTICALS INC | $7,400,559 | -11.7% | 216,644 | -0.5% | 1.36% | -6.7% |
| PODD | Sell | INSULET CORP | $6,702,567 | -60.0% | 42,025 | -27.6% | 1.23% | -57.7% |
| ANIP | Sell | ANI PHARMACEUTICALS INC | $6,491,224 | -30.9% | 111,802 | -35.9% | 1.19% | -27.0% |
| SUPN | Sell | SUPERNUS PHARMACEUTICALS INC | $3,809,402 | -33.4% | 138,172 | -27.3% | 0.70% | -29.6% |
| SILK | Sell | SILK RD MED INC | $3,737,622 | -62.6% | 249,341 | -18.9% | 0.68% | -60.5% |
| CTLT | Sell | CATALENT INC | $3,671,812 | -40.0% | 80,646 | -42.9% | 0.67% | -36.6% |
| LNTH | Sell | LANTHEUS HLDGS INC | $3,466,288 | -83.2% | 49,889 | -79.7% | 0.64% | -82.2% |
| Sell | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $3,037,701 | -25.5% | 53,293 | -33.4% | 0.56% | -21.2% | |
| PFMT | Sell | PERFORMANT FINL CORP | $2,936,610 | -24.8% | 1,299,385 | -10.2% | 0.54% | -20.5% |
| EVH | Sell | EVOLENT HEALTH INCcl a | $2,813,404 | -22.3% | 103,320 | -13.5% | 0.52% | -17.8% |
| BCYC | Sell | BICYCLE THERAPEUTICS PLCsponsored ads | $2,465,465 | -43.9% | 122,721 | -28.8% | 0.45% | -40.7% |
| NTRA | Sell | NATERA INC | $2,245,732 | -38.5% | 50,751 | -32.4% | 0.41% | -35.1% |
| ESPR | Sell | ESPERION THERAPEUTICS INC NE | $1,957,130 | -34.0% | 1,997,071 | -6.3% | 0.36% | -30.2% |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $1,758,343 | -59.4% | 210,580 | -35.3% | 0.32% | -57.1% |
| TGTX | Sell | TG THERAPEUTICS INC | $1,749,907 | -68.1% | 209,319 | -5.1% | 0.32% | -66.2% |
| LXRX | Sell | LEXICON PHARMACEUTICALS INC | $1,238,690 | -59.3% | 1,136,413 | -14.6% | 0.23% | -57.0% |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $971,042 | -51.6% | 141,758 | -26.8% | 0.18% | -48.9% |
| XFOR | Sell | X4 PHARMACEUTICALS INC | $872,000 | -88.1% | 800,000 | -78.8% | 0.16% | -87.4% |
| LQDA | Sell | LIQUIDIA CORPORATION | $743,384 | -66.3% | 117,253 | -58.3% | 0.14% | -64.5% |
| Sell | ASLAN PHARMACEUTICALS LTDspon ads new | $700,753 | -62.1% | 372,741 | -26.4% | 0.13% | -60.1% | |
| TERN | Sell | TERNS PHARMACEUTICALS INC | $209,892 | -76.6% | 41,728 | -59.3% | 0.04% | -75.5% |
| CDTX | Exit | CIDARA THERAPEUTICS INC | $0 | – | -136,011 | -100.0% | -0.03% | – |
| Exit | MINERALYS THERAPEUTICS INC | $0 | – | -11,658 | -100.0% | -0.03% | – | |
| SVRA | Exit | SAVARA INC | $0 | – | -206,607 | -100.0% | -0.11% | – |
| NSTG | Exit | NANOSTRING TECHNOLOGIES INC | $0 | – | -187,500 | -100.0% | -0.13% | – |
| GRTX | Exit | GALERA THERAPEUTICS INC | $0 | – | -540,847 | -100.0% | -0.29% | – |
| Exit | MARINUS PHARMACEUTICALS INC | $0 | – | -171,075 | -100.0% | -0.32% | – | |
| AXGN | Exit | AXOGEN INC | $0 | – | -260,858 | -100.0% | -0.41% | – |
| SWAV | Exit | SHOCKWAVE MED INC | $0 | – | -10,076 | -100.0% | -0.50% | – |
| KRMD | Exit | KORU MEDICAL SYSTEMS INC | $0 | – | -899,063 | -100.0% | -0.54% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -70,033 | -100.0% | -0.57% | – |
| IMVT | Exit | IMMUNOVANT INC | $0 | – | -216,868 | -100.0% | -0.71% | – |
| MMS | Exit | MAXIMUS INC | $0 | – | -50,381 | -100.0% | -0.74% | – |
| SGEN | Exit | SEAGEN INC | $0 | – | -22,602 | -100.0% | -0.75% | – |
| WAT | Exit | WATERS CORP | $0 | – | -40,688 | -100.0% | -1.88% | – |
| DHR | Exit | DANAHER CORPORATION | $0 | – | -60,696 | -100.0% | -2.52% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DEXCOM INC | 16 | Q3 2023 | 6.3% |
| ACLARIS THERAPEUTICS INC | 16 | Q3 2023 | 10.0% |
| XENON PHARMACEUTICALS INC | 16 | Q3 2023 | 3.3% |
| NATERA INC | 16 | Q3 2023 | 3.4% |
| AVID BIOSERVICES INC | 15 | Q3 2023 | 2.9% |
| SCHRODINGER INC | 15 | Q3 2023 | 4.2% |
| REPRO MED SYS INC | 15 | Q2 2023 | 2.0% |
| MANNKIND CORP | 15 | Q3 2023 | 1.6% |
| IQVIA HLDGS INC | 14 | Q1 2023 | 4.6% |
| INSULET CORP | 14 | Q3 2023 | 2.9% |
View Parkman Healthcare Partners LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| PLUS THERAPEUTICS, INC. | February 13, 2023 | 583,467 | 1.7% |
View Parkman Healthcare Partners LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Parkman Healthcare Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.